Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY84.50 CNY
Change Today -0.56 / -0.66%
Volume 4.1M
000513 On Other Exchanges
Symbol
Exchange
Shenzhen
Hong Kong
Frankfurt
As of 3:00 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

livzon pharmaceutical grou-a (000513) Snapshot

Open
CNY83.94
Previous Close
CNY85.06
Day High
CNY87.29
Day Low
CNY80.10
52 Week High
05/27/15 - CNY99.43
52 Week Low
06/3/14 - CNY45.30
Market Cap
22.1B
Average Volume 10 Days
5.5M
EPS TTM
CNY1.88
Shares Outstanding
192.4M
EX-Date
--
P/E TM
44.9x
Dividend
CNY0.10
Dividend Yield
0.59%
Current Stock Chart for LIVZON PHARMACEUTICAL GROU-A (000513)

Related News

No related news articles were found.

livzon pharmaceutical grou-a (000513) Related Businessweek News

No Related Businessweek News Found

livzon pharmaceutical grou-a (000513) Details

Livzon Pharmaceutical Group Inc. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products primarily include Chinese and Western drug preparation products, such as Shengqi Fuzheng Injection, a series of Bismuth Potassium Citrate Granules products, anti-viral granules, Urofollitropin for injection, Menotropins for injection, Ilaprazole, Voriconazole for injection, mouse nerve growth factor for injection, and Leuprorelin Acetate Microspheres for injection. The company’s products also comprise bulk medicines and intermediates, including Mevastatin, Colistin, Phenylalanine, Ceftriaxone Sodium, Cefuroxime Sodium, and Cefodizime Sodium; and diagnostic reagent products, such as ELISA HIV testing reagent, MYCOII testing reagent, and TPPA testing reagent. In addition, the company provides chemical drugs, biochemical drugs, microbiological preparations, and antibiotics; polypeptide bulk medicines; diagnostic reagents and equipment; human menopausal gonadotropin and human chorionic gonadotropin medicines; Omeprazole Sodium for injection; Ranitidine Bismuth Citrate tablets; Valaciclovir Hydrochloride tablets; Fluvoxamine Maleate tablet; Perospirone Hydrochloride tablets; and Prostant used for the treatment of clearing away heat evil and promoting diuresis. Further, it offers specialist bulk medicines and intermediates, such as fermented antibiotics, sterile cephalosporins, and hypolipidemic stantins. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China.

Founded in 1985

livzon pharmaceutical grou-a (000513) Top Compensated Officers

Vice Chairman, President, Member of Nominatio...
Total Annual Compensation: CNY790.6K
Chief Financial Officer and Vice President
Total Annual Compensation: CNY529.4K
Vice President and Executive Director
Total Annual Compensation: CNY589.3K
Chief Supervisor of the Legal Supervision Hea...
Total Annual Compensation: CNY294.8K
Company Secretary
Total Annual Compensation: CNY232.9K
Compensation as of Fiscal Year 2014.

livzon pharmaceutical grou-a (000513) Key Developments

Livzon Pharmaceutical Group Inc.(SZSE:000513) added to Shenzhen Stock Exchange Component A Share Index

Livzon Pharmaceutical Group Inc. has been added to Shenzhen Stock Exchange Component A Share Index.

Livzon Pharmaceutical Group Inc.(SZSE:000513) added to Shenzhen Stock Exchange Component Index

Livzon Pharmaceutical Group Inc. has been added to Shenzhen Stock Exchange Component Index.

Livzon Pharmaceutical Group Inc. Presents at Citigroup Inc. China A-Share Corporate Day 2015, May-08-2015

Livzon Pharmaceutical Group Inc. Presents at Citigroup Inc. China A-Share Corporate Day 2015, May-08-2015 . Venue: Mandarin Oriental Hotel, Hong Kong, Hong Kong.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000513:CH CNY84.50 CNY -0.56

000513 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000513.
View Industry Companies
 

Industry Analysis

000513

Industry Average

Valuation 000513 Industry Range
Price/Earnings 45.0x
Price/Sales 4.2x
Price/Book 6.1x
Price/Cash Flow 29.3x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIVZON PHARMACEUTICAL GROU-A, please visit www.livzon.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.